GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Total Assets

Kainos Medicine (XKRX:284620) Total Assets : ₩17,725.5 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Total Assets?

Kainos Medicine's Total Assets for the quarter that ended in Jun. 2024 was ₩17,725.5 Mil.

During the past 12 months, Kainos Medicine's average Total Assets Growth Rate was -56.80% per year. During the past 3 years, the average Total Assets Growth Rate was -2.70% per year. During the past 5 years, the average Total Assets Growth Rate was 103.30% per year.

During the past 7 years, Kainos Medicine's highest 3-Year average Total Assets Growth Rate was 5518.60%. The lowest was -2.70%. And the median was 204.55%.

Total Assets is connected with ROA %. Kainos Medicine's annualized ROA % for the quarter that ended in Jun. 2024 was -65.76%. Total Assets is also linked to Revenue through Asset Turnover. Kainos Medicine's Asset Turnover for the quarter that ended in Jun. 2024 was 0.01.


Kainos Medicine Total Assets Historical Data

The historical data trend for Kainos Medicine's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Total Assets Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 5,571.35 34,778.56 41,956.76 38,982.48 20,985.11

Kainos Medicine Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32,345.38 24,592.99 20,985.11 19,062.45 17,725.54

Kainos Medicine Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kainos Medicine's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=15771.123+5213.983
=20,985.1

Kainos Medicine's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=12283.817+5441.725
=17,725.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kainos Medicine  (XKRX:284620) Total Assets Explanation

Total Assets is connected with ROA %.

Kainos Medicine's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=-12095.448/( (19062.452+17725.542)/ 2 )
=-12095.448/18393.997
=-65.76 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kainos Medicine's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=176.674/( (19062.452+17725.542)/ 2 )
=176.674/18393.997
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kainos Medicine Total Assets Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine Headlines

No Headlines